126 related articles for article (PubMed ID: 22265853)
1. Retrospective study on the use of different protocols for repeated transarterial chemoembolization in the treatment of patients with hepatocellular carcinoma.
Vogl TJ; Naguib NN; Nour-Eldin NE; Farshid P; Lehnert T; Gruber-Rouh T; Engels KS
Acad Radiol; 2012 Apr; 19(4):434-9. PubMed ID: 22265853
[TBL] [Abstract][Full Text] [Related]
2. Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer.
Vogl TJ; Naguib NN; Nour-Eldin NE; Eichler K; Zangos S; Gruber-Rouh T
Eur Radiol; 2010 Jan; 20(1):173-80. PubMed ID: 19657653
[TBL] [Abstract][Full Text] [Related]
3. Repetitive transarterial chemoembolization (TACE) of liver metastases from gastric cancer: local control and survival results.
Vogl TJ; Gruber-Rouh T; Eichler K; Nour-Eldin NE; Trojan J; Zangos S; Naguib NN
Eur J Radiol; 2013 Feb; 82(2):258-63. PubMed ID: 23127803
[TBL] [Abstract][Full Text] [Related]
4. Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study.
Vogl TJ; Gruber T; Balzer JO; Eichler K; Hammerstingl R; Zangos S
Radiology; 2009 Jan; 250(1):281-9. PubMed ID: 19092099
[TBL] [Abstract][Full Text] [Related]
5. Initial experience with repetitive transarterial chemoembolization (TACE) as a third line treatment of ovarian cancer metastasis to the liver: indications, outcomes and role in patient's management.
Vogl TJ; Naguib NN; Lehnert T; Nour-Eldin NE; Eichler K; Zangos S; Gruber-Rouh T
Gynecol Oncol; 2012 Feb; 124(2):225-9. PubMed ID: 22079359
[TBL] [Abstract][Full Text] [Related]
6. Transarterial chemoembolization (TACE) using mitomycin and lipiodol with or without degradable starch microspheres for hepatocellular carcinoma: comparative study.
Gruber-Rouh T; Schmitt C; Naguib NNN; Nour-Eldin NA; Eichler K; Beeres M; Vogl TJ
BMC Cancer; 2018 Feb; 18(1):188. PubMed ID: 29444653
[TBL] [Abstract][Full Text] [Related]
7. Single-Agent versus Combination Doxorubicin-Based Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Single-Blind, Randomized, Phase II Trial.
Liu B; Huang JW; Li Y; Hu BS; He X; Zhao W; Zheng YB; Lu LG
Oncology; 2015; 89(1):23-30. PubMed ID: 25613214
[TBL] [Abstract][Full Text] [Related]
8. Transarterial Chemoembolization (TACE) Using Mitomycin with or without Irinotecan for Hepatocellular Carcinoma in European Patients.
Gruber-Rouh T; Kamal A; Eichler K; Naguib NN; Beeres M; Langenbach M; Vogl TJ
Oncol Res Treat; 2018; 41(7-8):438-442. PubMed ID: 30007958
[TBL] [Abstract][Full Text] [Related]
9. Liver metastases of neuroendocrine tumors: treatment with hepatic transarterial chemotherapy using two therapeutic protocols.
Vogl TJ; Gruber T; Naguib NN; Hammerstingl R; Nour-Eldin NE
AJR Am J Roentgenol; 2009 Oct; 193(4):941-7. PubMed ID: 19770314
[TBL] [Abstract][Full Text] [Related]
10. Response Evaluation Criteria in Solid Tumors (RECIST) criteria are superior to European Association for Study of the Liver (EASL) criteria at 1 month follow-up for predicting long-term survival in patients treated with transarterial chemoembolization before liver transplantation for hepatocellular cancer.
Shuster A; Huynh TJ; Rajan DK; Marquez MA; Grant DR; Huynh DC; Jaskolka JD
J Vasc Interv Radiol; 2013 Jun; 24(6):805-12. PubMed ID: 23562641
[TBL] [Abstract][Full Text] [Related]
11. Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy.
Kuhlmann JB; Euringer W; Spangenberg HC; Breidert M; Blum HE; Harder J; Fischer R
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):437-43. PubMed ID: 22261548
[TBL] [Abstract][Full Text] [Related]
12. Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment success.
Vogl TJ; Naguib NN; Nour-Eldin NE; Bechstein WO; Zeuzem S; Trojan J; Gruber-Rouh T
Int J Cancer; 2012 Aug; 131(3):733-40. PubMed ID: 21976289
[TBL] [Abstract][Full Text] [Related]
13. Single- versus Triple-Drug Chemoembolization for Hepatocellular Carcinoma: Comparing Outcomes by Toxicity, Imaging Response, and Survival.
Mouli SK; Hickey R; Thornburg B; Sato KT; Desai K; Gabr A; Kallini JR; Niemeri H; Kircher S; Mulcahy MF; Benson Iii AB; Gupta R; Salem R; Lewandowski RJ
J Vasc Interv Radiol; 2016 Sep; 27(9):1279-1287. PubMed ID: 27062355
[TBL] [Abstract][Full Text] [Related]
14. Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: long-term results over a 10-year period.
Gruber-Rouh T; Naguib NN; Eichler K; Ackermann H; Zangos S; Trojan J; Beeres M; Harth M; Schulz B; Nour-Eldin A NE; Vogl TJ
Int J Cancer; 2014 Mar; 134(5):1225-31. PubMed ID: 23960002
[TBL] [Abstract][Full Text] [Related]
15. Survival of patients with non-resectable, chemotherapy-resistant colorectal cancer liver metastases undergoing conventional lipiodol-based transarterial chemoembolization (cTACE) palliatively versus neoadjuvantly prior to percutaneous thermal ablation.
Vogl TJ; Lahrsow M; Albrecht MH; Hammerstingl R; Thompson ZM; Gruber-Rouh T
Eur J Radiol; 2018 May; 102():138-145. PubMed ID: 29685527
[TBL] [Abstract][Full Text] [Related]
16. Repetitive transarterial chemoembolization (TACE) of liver metastases from renal cell carcinoma: local control and survival results.
Nabil M; Gruber T; Yakoub D; Ackermann H; Zangos S; Vogl TJ
Eur Radiol; 2008 Jul; 18(7):1456-63. PubMed ID: 18309493
[TBL] [Abstract][Full Text] [Related]
17. Repeated chemoembolization followed by laser-induced thermotherapy for liver metastasis of breast cancer.
Vogl TJ; Naguib NN; Nour-Eldin NE; Mack MG; Zangos S; Abskharon JE; Jost A
AJR Am J Roentgenol; 2011 Jan; 196(1):W66-72. PubMed ID: 21178035
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for transarterial chemoembolization in patients with unresectable hepatocellular carcinoma.
Wu J; Song L; Zhao DY; Guo B; Liu J
World J Gastroenterol; 2014 Aug; 20(31):10960-8. PubMed ID: 25152600
[TBL] [Abstract][Full Text] [Related]
19. Transarterial chemoembolization for treatment of hepatocellular carcinoma: A single center experience.
Idilman I; Peynircioğlu B; Cil BE; Doğanay Erdoğan B; Yalçın S; Bayraktar Y; Kav T; Altundağ K; Balkancı F
Turk J Gastroenterol; 2013; 24(2):141-7. PubMed ID: 23934461
[TBL] [Abstract][Full Text] [Related]
20. Comparison of characteristics and transarterial chemoembolization outcomes in patients with unresectable hepatocellular carcinoma and different viral etiologies.
Chen BB; Shih IL; Wu CH; Hsu C; Chen CH; Shih TT; Liu KL; Liang PC
J Vasc Interv Radiol; 2014 Mar; 25(3):371-8. PubMed ID: 24468045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
